1,2,4-Triazolo[3,4-a]pyridine as a novel, constrained template for fibrinogen receptor (GPIIb/IIIa) antagonists
Bioorganic & Medicinal Chemistry Letter;
11;19; 2001; 2619 - 2622;
Код: Выделить всё
http://dx.doi.org/10.1016/S0960-894X(01)00529-7Potent 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists: effects of fused heterocycles on antiviral activity and pharmacokinetic properties
Bioorganic & Medicinal Chemistry Letters;
15; 8; 2005; 2129 - 2134;
Код: Выделить всё
http://dx.doi.org/10.1016/j.bmcl.2005.02.030Structure–activity relationships of triazolopyridine oxazole p38 inhibitors: Identification of candidates for clinical development
Bioorganic & Medicinal Chemistry Letters
16; 16; 2006; 4339 - 4344;
Код: Выделить всё
http://dx.doi.org/10.1016/j.bmcl.2006.05.056Synthesis and structure-activity relationship of C-3 quaternary ammonium cephalosporins exhibiting anti-MRSA activities
Bioorganic & Medicinal Chemistry Letters
7; 21; 1997; 2753 - 2758;
Код: Выделить всё
http://dx.doi.org/10.1016/S0960-894X(97)10078-6